ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
CalciMedica Inc

CalciMedica Inc (CALC)

4.16
-0.25
(-5.67%)
Closed September 12 4:00PM
4.16
0.00
( 0.00% )
Pre Market: 4:09AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
4.16
Bid
1.68
Ask
6.46
Volume
1
0.00 Day's Range 0.00
1.75 52 Week Range 8.59
Market Cap
Previous Close
4.16
Open
-
Last Trade
1
@
4.48
Last Trade Time
04:13:20
Financial Volume
-
VWAP
-
Average Volume (3m)
35,275
Shares Outstanding
10,750,156
Dividend Yield
-
PE Ratio
-1.30
Earnings Per Share (EPS)
-3.2
Revenue
-
Net Profit
-34.36M

About CalciMedica Inc

CalciMedica, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for life-threatening inflammatory diseases with high unmet needs. Its technology targets the inhibition of Calcium Release-Activated Calcium (CRAC) channels designed to modulate the immune... CalciMedica, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for life-threatening inflammatory diseases with high unmet needs. Its technology targets the inhibition of Calcium Release-Activated Calcium (CRAC) channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases. CRAC channels serve to replenish calcium levels in the endoplasmic reticulum (ER) and provide calcium for cellular signaling events. Its lead product candidate, Auxora, is an intravenous-formulated, small molecule CRAC channel inhibitor. Auxora has the capability to modulate the immune response and protect against tissue cell injury, addressing inflammatory diseases, such as acute pancreatitis (AP), asparaginase-associated acute pancreatitis (AAP), acute kidney injury (AKI), and acute hypoxemic respiratory failure. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
CalciMedica Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CALC. The last closing price for CalciMedica was $4.16. Over the last year, CalciMedica shares have traded in a share price range of $ 1.75 to $ 8.59.

CalciMedica currently has 10,750,156 shares outstanding. The market capitalization of CalciMedica is $44.72 million. CalciMedica has a price to earnings ratio (PE ratio) of -1.30.

CALC Latest News

CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference

CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference PR Newswire LA JOLLA, Calif., Sept. 3, 2024 LA JOLLA, Calif., Sept. 3, 2024 /PRNewswire/ -- CalciMedica Inc...

CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates PR Newswire LA JOLLA, Calif., Aug. 12, 2024 Positive topline data announced from CARPO...

CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora™ in Severe Acute Kidney Injury (AKI)

CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora™ in Severe Acute Kidney Injury (AKI) PR Newswire LA JOLLA, Calif., July 9, 2024 Development of Auxora in AKI is...

CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences

CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences PR Newswire LA JOLLA, Calif., July 8, 2024 LA JOLLA, Calif., July 8, 2024 /PRNewswire/ -- CalciMedica Inc...

CalciMedica Set to Join Russell Microcap® Index

CalciMedica Set to Join Russell Microcap® Index PR Newswire LA JOLLA, Calif., July 1, 2024 LA JOLLA, Calif., July 1, 2024 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company...

CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) PR Newswire LA JOLLA, Calif., June 27, 2024 Primary objective of the trial met with...

CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) PR Newswire LA JOLLA, Calif., June 26, 2024 Conference call and webcast...

CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates PR Newswire LA JOLLA, Calif., May 13, 2024 Last patient enrolled in CARPO, Phase 2b trial of...

CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024

CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024 PR Newswire LA JOLLA, Calif., May 7, 2024 Collaborators from Cedars-Sinai to present human proteomics data supporting...

CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis

CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis PR Newswire LA JOLLA, Calif., April 24, 2024 Full target enrollment of 216 patients...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.092.21130221134.075.972.91638614.60427705CS
4-1.01-19.53578336565.175.972.91544864.21410299CS
12-0.33-7.349665924284.496.2652.91352754.40278177CS
260.8927.21712538233.278.381.75266594.1966244CS
52-1.11-21.06261859585.278.591.75254764.22611233CS
156-1.11-21.06261859585.278.591.75254764.22611233CS
2600005.97000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TNONTenon Medical Inc
$ 42.50
(865.91%)
1.22M
VMARVision Marine Technologies Inc
$ 3.20
(113.33%)
6.13M
SMXSMX Security Matters Public Company
$ 4.43
(80.82%)
1.42M
OMICSingular Genomics Systems Inc
$ 8.66
(53.27%)
221.74k
SEELSeelos Therapeutics Inc
$ 0.241
(27.18%)
511
VEEETwin Vee PowerCats Company
$ 0.2501
(-44.42%)
6
CNEYCN Energy Group Inc
$ 0.5398
(-21.77%)
466.18k
WLGSWang and Lee Group Inc
$ 1.14
(-19.72%)
32.06k
GVVisionary Holdings Inc
$ 3.56
(-19.46%)
105.53k
QHQuhuo Ltd
$ 1.00
(-18.03%)
128.5k
VMARVision Marine Technologies Inc
$ 3.20
(113.33%)
6.13M
IMRXImmuneering Corporation
$ 1.81
(26.57%)
3.59M
XXII22nd Century Group Inc
$ 0.2695
(0.07%)
2.66M
SMXSMX Security Matters Public Company
$ 4.43
(80.82%)
1.42M
SMFLSmart for Life Inc
$ 1.21
(0.00%)
1.34M

Your Recent History

Delayed Upgrade Clock